Search research articles
Contact Us
Filters
Showing results (1431-1440 of 1,553) with videos related to
Page
of 156
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Jia Liu, Max Farrow, Lesley Seymour, et al.
Hepatobiliary Surgery and Nutrition
|
April 15, 2026
Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis
Kanglian Zheng, Shijie Fu, Xu Zhu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
September 27, 2017
Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor
Jian Li, Yingjiang Ye, Jian Wang, et al.
The Oncologist
|
May 30, 2024
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer
Wasat Mansoor, Seongjung Joo, Josephine M Norquist, et al.
Cancer Immunology, Immunotherapy : CII
|
March 8, 2025
Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies
Zhihao Lu, Guoping Sun, Jiancheng Li, et al.
The Biochemical Journal
|
February 1, 2018
Mechanistic insights into the allosteric regulation of <i>Pseudomonas aeruginosa</i> aspartate kinase
Chang-Cheng Li, Mei-Jia Yang, Li Liu, et al.
The New England Journal of Medicine
|
May 30, 2025
Encorafenib, Cetuximab, and mFOLFOX6 in <i>BRAF</i>-Mutated Colorectal Cancer
Elena Elez, Takayuki Yoshino, Lin Shen, et al.
Signal Transduction and Targeted Therapy
|
March 14, 2025
PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial
Yakun Wang, Jialin Lu, Xiaoyi Chong, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
April 3, 2026
Danshensu ameliorates doxorubicin cardiotoxicity by attenuating oxidative stress and JNK-mediated mitochondrial dysfunction
Xuemei Wang, Wenjing Huang, Lin Shen, et al.
Cancer Medicine
|
December 14, 2022
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
Min-Hee Ryu, Kyung Hee Lee, Lin Shen, et al.
Page
of 156
Search research articles
Search
Showing results (1431-1440 of 1,553) with videos related to
Sort By:
Page
of 156
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Jia Liu, Max Farrow, Lesley Seymour, et al.
Hepatobiliary Surgery and Nutrition
|
April 15, 2026
Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis
Kanglian Zheng, Shijie Fu, Xu Zhu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
September 27, 2017
Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor
Jian Li, Yingjiang Ye, Jian Wang, et al.
The Oncologist
|
May 30, 2024
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer
Wasat Mansoor, Seongjung Joo, Josephine M Norquist, et al.
Cancer Immunology, Immunotherapy : CII
|
March 8, 2025
Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies
Zhihao Lu, Guoping Sun, Jiancheng Li, et al.
The Biochemical Journal
|
February 1, 2018
Mechanistic insights into the allosteric regulation of <i>Pseudomonas aeruginosa</i> aspartate kinase
Chang-Cheng Li, Mei-Jia Yang, Li Liu, et al.
The New England Journal of Medicine
|
May 30, 2025
Encorafenib, Cetuximab, and mFOLFOX6 in <i>BRAF</i>-Mutated Colorectal Cancer
Elena Elez, Takayuki Yoshino, Lin Shen, et al.
Signal Transduction and Targeted Therapy
|
March 14, 2025
PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial
Yakun Wang, Jialin Lu, Xiaoyi Chong, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
April 3, 2026
Danshensu ameliorates doxorubicin cardiotoxicity by attenuating oxidative stress and JNK-mediated mitochondrial dysfunction
Xuemei Wang, Wenjing Huang, Lin Shen, et al.
Cancer Medicine
|
December 14, 2022
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
Min-Hee Ryu, Kyung Hee Lee, Lin Shen, et al.
Page
of 156